Brooks Leitner, MD, PhD, is the CEO and Co-Founder of VO Health, a venture-backed applied biotech company commercializing the next generation of biomarkers of healthspan and performance. With over 30 peer-reviewed publications and 1,700+ citations in metabolism, physiology, and translational research, Brooks brings a unique perspective at the intersection of cutting-edge science and practical application. He trained at Yale University and the NIH, serves on the Physician Advisory Council of the Medical Fitness Association, and has experience spanning biomedical research, venture capital, and company building. He is a second-time founder, having previously launched a epigenetics therapeutics startup where he raised early capital and recruited executive leadership. He then worked in biotech venture capital at Canaan, Foresite Capital, ACS BrightEdge, and PsyMed Ventures.